Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
0.00%
)
US TECH 100
26,344.40
(
0.16%
)
Dow Jones
49,141.93
(
0.00%
)
Brent Oil
108.07
(
3.50%
)
Bitcoin
77,174.42
(
1.09%
)
News Focus
News Focus

Replies to post #250720 on Biotech Values

Replies to #250720 on Biotech Values
icon url

DewDiligence

02/23/24 11:41 AM

#250726 RE: dewophile #250720

VIR—That’s quite a burn rate.

Indeed. The majority of the 2024 operating expenses will go toward the HDV and HBV programs.

4Q23 CC slides:
https://investors.vir.bio/files/doc_presentations/2024/02/22/Vir-Corporate-Presentation_Q4-2023.pdf
icon url

DewDiligence

10/31/24 4:44 PM

#253502 RE: dewophile #250720

VIR reports 3Q24 results—9/30/24 cash=$1.19B:

https://www.businesswire.com/news/home/20241031806056/en